Maturation functions of the HSV-1 tegument

HSV-1 外皮的成熟功能

基本信息

  • 批准号:
    7388178
  • 负责人:
  • 金额:
    $ 31.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-01 至 2011-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Herpesviruses are important human pathogens that result in life-long persistent infections with numerous clinical manifestations. Herpes simplex virus (HSV) is among the most frequently encountered pathogen by the general population. Thus understanding the biology of this virus is important in the development of efficacious treatments of these infections. Our goal is to understand the mechanism by which the virus acquires its infectious coat and the role of the virus encoded functions in this pathway, primarily by analyzing the functions of two tegument proteins, the UL36 and UL37 gene products. Our hypothesis is that the UL36 and UL37 gene products specify essential and unique functions for the maturation of the assembled particle into an infectious virion. The goals of this proposal are to understand how these two proteins function in the morphogenesis of the infectious particle, identification of the functional domains required for these activities and the interactions that occur during this process. This could potentially lead to the discovery of novel pathways that can be targeted by antiviral intervention. The specific aims to achieve these goals are: Specific Aim 1: Investigating the role of UL36 and UL37 in the maturation of the virus particle using mutant viruses. UL36 may act to translocate capsids to the cytoplasmic site for final envelopment, whereas, UL37 is required for Golgi stabilization prior to the arrival of capsids at this site. Light microscopy, electron microscopy and immuno-EM assays will be used to determine the association of UL36 mutant virus particles with the cellular cytoskeleton and analyze axonal transport in primary neurons. The Golgi structure will be analyzed in the presence and absence of UL37 and the contribution of UL36, capsid assembly and cis-acting signals for facilitating Golgi stabilization will be determined. Specific Aim 2: Protein-protein interactions of UL36 and UL37 with virus and cellular proteins. Protein-protein interactions are critical for a variety of viral and cellular processes. The UL36 and UL37 encoded polypeptides will be used as probes to identify protein-protein interactions using a combination of cell biology (cellular localization), genetic (yeast two-hybrid), biochemical (protein pull-down) assays. Specific Aim 3: Structural studies of UL36 and UL37 in capsids and the mature virion. A capsid binding assay and cryo-electron tomography imaging of virions will illuminate the association of these proteins with a multi-protein assembly (capsid/virion). Structural data is important for understanding how these proteins function in virus egress. Specific Aim 4: Identification of functional domains of UL36 and UL37. Transposon and site-directed mutagenesis will be used to identify functional domains of the UL36 and UL37 genes. Genetic complementation assays will be used to screen the mutants for functional activity. Mutations that specify lethal defects in function will be introduced into the virus using a marker-rescue/marker-transfer method. The outcome will be a functional map of UL36 and UL37 that identifies domains important for capsid translocation, Golgi stabilization, Golgi trafficking, virion incorporation and protein-protein interactions This analysis will identify domains of the proteins that have the potential to be used as targets for antiviral intervention
描述(由申请人提供):疱疹病毒是重要的人类病原体,可导致具有多种临床表现的终身持续性感染。单纯疱疹病毒(HSV)是普通人群中最常见的病原体之一。因此,了解这种病毒的生物学特性对于开发有效治疗这些感染的方法非常重要。我们的目标是通过分析两个被膜蛋白UL36和UL37基因产物的功能,了解病毒获得感染外壳的机制以及病毒编码功能在这一途径中的作用。我们的假设是UL36和UL37基因产物为组装颗粒成熟为感染性病毒粒子指定了必要和独特的功能。本研究的目标是了解这两种蛋白在感染性颗粒的形态发生中如何起作用,确定这些活动所需的功能域以及在此过程中发生的相互作用。这可能会导致发现抗病毒干预的新途径。具体目标1:利用突变病毒研究UL36和UL37在病毒颗粒成熟过程中的作用。UL36可能会将衣壳转移到细胞质位点进行最终包膜,而UL37则需要在衣壳到达该位点之前实现高尔基稳定。光镜、电镜和免疫电镜检测将用于确定UL36突变病毒颗粒与细胞骨架的关联,并分析初级神经元的轴突运输。我们将在UL37存在和不存在的情况下分析高尔基结构,并确定UL36、衣壳组装和顺式作用信号对促进高尔基稳定的贡献。特异性目标2:UL36和UL37与病毒和细胞蛋白的蛋白相互作用。蛋白质之间的相互作用对各种病毒和细胞过程至关重要。UL36和UL37编码的多肽将作为探针使用细胞生物学(细胞定位),遗传学(酵母双杂交),生化(蛋白质拉下)测定的组合来识别蛋白质-蛋白质相互作用。具体目标3:衣壳和成熟病毒粒子中UL36和UL37的结构研究。衣壳结合试验和病毒粒子的冷冻电子断层成像将阐明这些蛋白质与多蛋白质组装(衣壳/病毒粒子)的关联。结构数据对于了解这些蛋白质在病毒输出过程中如何发挥作用非常重要。具体目标4:鉴定UL36和UL37的功能域。转座子和定点诱变将用于鉴定UL36和UL37基因的功能域。基因互补试验将用于筛选突变体的功能活性。将使用标记拯救/标记转移方法将指定功能致命缺陷的突变引入病毒。结果将是UL36和UL37的功能图谱,确定衣壳易位、高尔基稳定、高尔基运输、病毒粒子结合和蛋白质-蛋白质相互作用的重要结构域。该分析将确定有可能用作抗病毒干预靶点的蛋白质结构域

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PRASHANT J DESAI其他文献

PRASHANT J DESAI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PRASHANT J DESAI', 18)}}的其他基金

Elucidation of genetic networks of HSV-1 virion proteins and discovery of their functions in the morphogenesis of the infectious virus particle
阐明 HSV-1 病毒体蛋白的遗传网络并发现它们在感染性病毒颗粒形态发生中的功能
  • 批准号:
    10319969
  • 财政年份:
    2019
  • 资助金额:
    $ 31.24万
  • 项目类别:
Synthetic Genomics Approach to Assemble Infectious Clones of KSHV
组装 KSHV 感染性克隆的合成基因组学方法
  • 批准号:
    9807969
  • 财政年份:
    2019
  • 资助金额:
    $ 31.24万
  • 项目类别:
Engineering Herpesviruses using Synthetic Genomics
使用合成基因组学改造疱疹病毒
  • 批准号:
    8893391
  • 财政年份:
    2015
  • 资助金额:
    $ 31.24万
  • 项目类别:
Development of a virion display (VirD) array to profile human GPCR interactions
开发病毒粒子展示 (VirD) 阵列来分析人类 GPCR 相互作用
  • 批准号:
    9247705
  • 财政年份:
    2015
  • 资助金额:
    $ 31.24万
  • 项目类别:
How does the KSHV small capsid protein function to promote self-assembly?
KSHV 小衣壳蛋白如何发挥促进自组装的作用?
  • 批准号:
    8733130
  • 财政年份:
    2013
  • 资助金额:
    $ 31.24万
  • 项目类别:
Bridging KSHV capsids to the nuclear egress complex
将 KSHV 衣壳桥接至核出口复合体
  • 批准号:
    8570507
  • 财政年份:
    2013
  • 资助金额:
    $ 31.24万
  • 项目类别:
How does the KSHV small capsid protein function to promote self-assembly?
KSHV 小衣壳蛋白如何发挥促进自组装的作用?
  • 批准号:
    8570572
  • 财政年份:
    2013
  • 资助金额:
    $ 31.24万
  • 项目类别:
Maturation functions of the HSV-1 tegument
HSV-1 外皮的成熟功能
  • 批准号:
    8070311
  • 财政年份:
    2010
  • 资助金额:
    $ 31.24万
  • 项目类别:
Maturation functions of the HSV-1 tegument
HSV-1 外皮的成熟功能
  • 批准号:
    7846535
  • 财政年份:
    2009
  • 资助金额:
    $ 31.24万
  • 项目类别:
Generation and Evaluation of KSHV VLPs as Vaccines
KSHV VLP 作为疫苗的生成和评估
  • 批准号:
    7853673
  • 财政年份:
    2009
  • 资助金额:
    $ 31.24万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 31.24万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 31.24万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 31.24万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 31.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 31.24万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 31.24万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 31.24万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 31.24万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 31.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 31.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了